- Home
- ONEG vs CPHI Comparison
ONEG vs CPHI Comparison
Compare ONEG & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ONEG | CPHI |
|---|---|---|
| Founded | 2021 | N/A |
| Country | Hong Kong | China |
| Employees | 26 | N/A |
| Industry | Homebuilding | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.3M | 31.2M |
| IPO Year | N/A | 2008 |
Fundamental Metrics
Financial Performance| Metric | ONEG | CPHI |
|---|---|---|
| Price | $1.16 | $0.60 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 253.2K | ★ 1.4M |
| Earning Date | 01-14-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,144,268.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.72 | $0.38 |
| 52 Week High | $14.95 | $2.00 |
Technical Indicators
Market Signals| Indicator | ONEG | CPHI |
|---|---|---|
| Relative Strength Index (RSI) | 42.44 | 46.51 |
| Support Level | $1.13 | $0.54 |
| Resistance Level | $1.98 | $0.68 |
| Average True Range (ATR) | 0.19 | 0.12 |
| MACD | 0.03 | -0.01 |
| Stochastic Oscillator | 7.69 | 23.05 |
Price Performance
Historical ComparisonAbout ONEG OneConstruction Group Limited Ordinary Shares
OneConstruction Group Ltd is a structural steelwork contractor in Hong Kong. The company is engaged in the procurement and installation of structural steel for construction projects in Hong Kong. Its construction project includes performing site preparatory and preliminary works, developing detailed work schedules and work allocation plans, implementing construction site works, and conducting site safety supervision and quality control.
About CPHI China Pharma Holdings Inc.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.